Notable Analyst Rating Changes 04/29: (CL) (DISCA) (UIS) Upgraded; (RIMM) (OSK) (IM) Downgraded

FREE Breaking News Alerts from StreetInsider.com!

CL Hot Sheet

Overall Analyst Rating:
NEUTRAL (= Flat)

Dividend Yield: 2.5%
EPS Growth %: +6.9%

UPGRADES
Deutsche Bank lifts Colgate-Palmolive Company (NYSE: CL) from Hold to Buy, increasing its price target to $92. Click Here for more color.

Barrington Research raises Discovery Communications (Nasdaq: DISCA) from Market Perform to Outperform, boosting its price target to $55. Click Here for more color.

Susquehanna ups Unisys (NYSE: UIS) from Negative to Neutral.

HSBC upgrades Boeing (NYSE: BA) from Underweight to Neutral, boosting its price target from $63 to $82.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Research In Motion (Nasdaq: RIMM) receives a multitude of downgrades today:

Jefferies from Buy to Underperform, cutting their price target from $80 to $35. Click Here for more color;
National Bank from Outperform to Market Perform, with a price target slashed from $80 to $50;
RBC Capital from Top Pick to Sector Perform; and
Gleacher & Co. from Buy to Neutral, price target lowered from $72 to $56.

Oshkosh (NYSE: OSK) lowered by three today:

Baird from Outperform to Neutral, price target lowered from $47 to $34;
Goldman Sachs from Buy to Neutral and cut their price target from $44 to $37. Click Here for more color; and
Benchmark from Buy to Hold., setting a new price target of $35. Click Here for more color.

Ingram Micro (NYSE: IM) reduced by a slew of firms:

Goldman Sachs removed it from their Conviction Buy List. Click Here for more color;
Stifel Nicolaus from Buy to Hold; and
Brean Murray Carret & Co. from Buy to Hold.

Gen-Probe (Nasdaq: GPRO) receives a downgrade from several firms today:

William Blair from Outperform to Market Perform;
Gleacher & Co. from Buy to Neutral;
Canaccord Genuity from Buy to Hold, increasing its price target from $75 to $88; and
Piper Jaffray from Overweight to Neutral, and price target to $78.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
JPMorgan initiates CenturyLink, Inc. (NYSE: CTL) with an Overweight, and $45 price target.

Brean Murray Carret & Co. starts Salix Pharmaceuticals (Nasdaq: SLXP) with a Buy, and $50 price target. Click Here for more color.

Auriga assumes United Therapeutics Corp. (Nasdaq: UTHR) with a Buy rating and $90 price target. Click Here for more color.

Canaccord Genuity initiates coverage on Transocean (NYSE: RIG) with a Hold, and $85 price target.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!